Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Johnson and Johnson
Dow
McKesson

Last Updated: May 27, 2022

Investigational Drug Information for N,N-Dimethyltryptamine


✉ Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug N,N-Dimethyltryptamine?

N,N-Dimethyltryptamine is an investigational drug.

There have been 11 clinical trials for N,N-Dimethyltryptamine. The most recent clinical trial was a Phase 2 trial, which was initiated on April 1st 2007.

The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Anxiety Disorders. The leading clinical trial sponsors are Johns Hopkins University, Heffter Research Institute, and Joshua Woolley, MD/PhD.

Recent Clinical Trials for N,N-Dimethyltryptamine
TitleSponsorPhase
Acute Dose-dependent Effects of DMT in Healthy Subjects: A Placebo-controlled Cross-over StudyUniversity Hospital, Basel, SwitzerlandPhase 1
Psilocybin Therapy for Chronic Low Back PainJoshua Woolley, MD/PhDPhase 1/Phase 2
Effects of Psilocybin on Electrophysiology and the Dynamic Content of ThoughtJohns Hopkins UniversityPhase 1/Phase 2

See all N,N-Dimethyltryptamine clinical trials

Clinical Trial Summary for N,N-Dimethyltryptamine

Top disease conditions for N,N-Dimethyltryptamine
Top clinical trial sponsors for N,N-Dimethyltryptamine

See all N,N-Dimethyltryptamine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Colorcon
Johnson and Johnson
Dow
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.